Rachel Nusbaum

Rachel Nusbaum

Auto-generated profile, based on publicly available information

Rachel Nusbaum

University of Maryland School of Medicine Baltimore Maryland USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 August 2021 in Journal of Genetic Counseling
Verified
Journal Article
Closed access
PDF file
NDNoelle R. Danylchuk
Noelle R. Danylchuk
LCLola Cook
Lola Cook
KSKate P. Shane‐Carson
Kate P. Shane‐Carson
CCCara N. Cacioppo
Cara N. Cacioppo
MHMelanie W. Hardy
Melanie W. Hardy
JMJennifer Malinowski
Jennifer Malinowski

17 May 2014 in Psycho-Oncology
Verified
Journal Article
Open access
PDF file
ATAngie Tong
Angie Tong
SKScott Kelly
Scott Kelly
RNRachel Nusbaum
Rachel Nusbaum
KGKristi Graves
Kristi Graves
BPBeth N. Peshkin
Beth N. Peshkin
MSMarc Schwartz
Marc Schwartz
Objective Genetic testing for breast and ovarian cancer susceptibility is now part of routine clinical practice. Although rates of risk‐reducing surgery following genetic testing have been increasing, little is known about attitudes toward risk‐reducing surgery in women prior to genetic counseling and testing. This study examines correlates of patient intentions to undergo risk‐reducing mastectomy (RRM) and risk‐reducing oophorectomy (RRO). Methods Participants were 696 women, ages 21–85, who sought breast cancer gene 1 and 2 (BRCA1/2) genetic counseling and had at least a 10% risk of carrying a mutation. The sample included women who were affected with breast or ovarian cancer and unaffected women with a known familial BRCA1/2 mutation. Participants completed a precounseling telephone questionnaire. Results Prior to receiving genetic counseling, 23.3% of participants were considering RRM and 42.5% were considering RRO. Variables that were independently associated with RRM intentions were cancer‐specific distress (OR = 1.14, 95% CI = 1.03–1.26), perceived risk of breast cancer (OR = 1.16, 95% CI = 1.05–1.28), education (OR = 1.76, 95% CI = 1.03–2.99), and age (OR = 0.96, 95% CI = 0.95–0.98). Predictors of RRO intentions were perceived risk for ovarian cancer (OR = 1.25, 95% CI = 1.14–1.37), perceived risk of carrying a BRCA1/2 mutation (OR = 1.74, 95% CI = 1.15–2.62), marital status (OR = 1.92, 95% CI = 1.34–2.76), and age (OR = 1.02, 95% CI = 1.00–1.03). Conclusions Because precounseling intentions predict subsequent risk‐reducing surgery decisions, this study identified patient factors associated with surgical intentions. These factors reinforce the critical role for pretest genetic counseling in communicating accurate risk estimates and management options, and addressing psychosocial concerns, to facilitate informed decision making regarding RRM and RRO. Copyright © 2014 John Wiley & Sons, Ltd.